Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$240M |
| 2 |
Coca-Cola
KO
|
+$205M |
| 3 |
Amazon
AMZN
|
+$178M |
| 4 |
Qualcomm
QCOM
|
+$173M |
| 5 |
Bausch Health
BHC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$478M |
| 2 |
Chevron
CVX
|
+$466M |
| 3 |
IBM
IBM
|
+$388M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$303M |
| 5 |
Microsoft
MSFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Staples | 18.09% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 5.93% |
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2014 Portfolio in Review
As of Q4 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 493 positions worth $37.1B, down 1.6% from $37.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.16B in Q4 2014, closing 52 positions and reducing 258 holdings. Its most notable exit was Shire pic, an estimated $478M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in AUXILIUM PHARAMCEUTICALS INC worth $44.1M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2014 buy was AUXILIUM PHARAMCEUTICALS INC: 1,281,312 shares worth $44.1M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to iShares MSCI Emerging Markets ETF in Q4 2014, an estimated $240M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2014 reduction was Chevron, cutting an estimated $466M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Shire pic in Q4 2014, selling an estimated $478M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 41% of its $37.1B portfolio in Q4 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 61 new positions and closed 52 in Q4 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 1.6% quarter-over-quarter to $37.1B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2014, filed 13 Feb 2015.